Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kozlovsky, N. Articles by Agam, G. Search for Related Content PubMed Citation Articles by Kozlovsky, N. Articles by Agam, G. Neurophysiology Cognition

Low GSK-3ß Immunoreactivity in Postmortem Frontal Cortex of Schizophrenic Patients

OBJECTIVE: Glycogen synthase kinase-3 (GSK-3) is a protein kinase that is highly abundant in the brain. It is involved in signal transduction cascades of multiple cellular processes, particularly neurodevelopment. In an attempt to explore possible involvement of GSK-3ß in psychiatric disorders, the authors examined its levels in postmortem brain tissue.METHOD: Western blot analysis was performed to measure GSK-3ß in the frontal cortex of 14 schizophrenic patients, 15 patients with bipolar disorder, 15 patients with unipolar depression, and 14 normal comparison subjects.RESULTS: GSK-3ß levels were 41% lower in the schizophrenic patients than in the comparison subjects. Other diagnostic groups did not differ from the comparison subjects.CONCLUSIONS: These results are consistent with the notion that schizophrenia involves neurodevelopmental pathology. It remains to be investigated whether the active fraction of GSK-3ß, or its activity, is also low in frontal cortex of schizophrenic patients and if this is also reflected in other brain regions.

This article has been cited by other articles:

				F. Fumagalli, A. Frasca, M. Sparta, F. Drago, G. Racagni, and M. A. Riva Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently Up-Regulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex Mol. Pharmacol., April 1, 2006; 69(4): 1366 - 1372. [Abstract] [Full Text] [PDF]

				B Dean Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue Postgrad. Med. J., March 1, 2002; 78(917): 142 - 148. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us